"Is there a natural, non-addictive, and non-anti-reward, safe, gene-based solution to treat Reward Deficiency Syndrome (RDS)? KB220 variants vs. GLP-1 analogs" has now been accepted for publication

This is in the Journal of Addiction Psychiatry

Link to PDF